Tech Company Financing Transactions
Valitor Funding Round
Valitor secured a $28 million Series B funding round on 10/6/2022. Backers included Morningside Group, Berkeley Catalyst Fund and ExSight Capital.
Transaction Overview
Company Name
Announced On
10/6/2022
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support its programs in ophthalmology and vision-threatening diseases, utilizing its Multivalent Polymer technology platform that originated at U.C. Berkeley.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2630 Bancroft Ave.
Berkeley, CA 94704
USA
Berkeley, CA 94704
USA
Phone
Website
Email Address
Overview
Valitor is conquering limitations of established drug targets by leveraging its multi-valent biopolymer technology to maximize benefits for patients. The company is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Lo
President
Wesley Jackson
VP - Bus. Development
William White
Browse more venture capital transactions:
Prev: 10/6/2022: Iconic Air venture capital transaction
Next: 10/6/2022: Qunnect venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs